The share market is just that a “market”.
The price was higher when management needed more capital and spent some effort spruiking the business to raise capital. They now have enough cash for at least 2 years unless they have some other grand plan like an acquisition.
The only reason management wouldn’t want the sp too low is it’s harder to get the sp up from a low base for the next cap raise.
As for a management buy out, the spread of share holders is too wide, I have seen it happen but even with a 55% grip it was still difficult.
They will need so much more capital in the future for the Midkine portfolio why would you cut off your access to market funding?
Selling off Advangen to one of Dennis Eck’s subsidiaries for peanuts would be criminal though!
I can only see positives going forward. but we are playing the long game. At least another two years.
On an another note:
No one has really picked on Australian Evolis sales, they are bloody terrible and I get the feeling we are spending an extra ordinary amount on its promotion. It could be that we need that Australian base to launch into China, a but like the milk powder demand.
Its all my opinion and experiences so feel free to comment.
